# SEMGLEE

NDC: 83257-012
Generic name: insulin glargine-yfgn
Labeler / Manufacturer: Biocon Biologics Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20230728
Marketing ended: 20270531
FDA application: BLA761201

## Active ingredients

- INSULIN GLARGINE: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83257-012"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83257-012
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8cf5544f-87d6-468b-f6ae-898b1fdb5d80